<DOC>
	<DOCNO>NCT01261117</DOCNO>
	<brief_summary>To determine whether oral intravenous ibuprofen well efficacy tolerance closure patent ductus arteriosis extremely-low-birth-weight preterm infant .</brief_summary>
	<brief_title>Efficacy Safety Oral Versus Intravenous Ibuprofen PDA Treatment ELBW Infants</brief_title>
	<detailed_description>To determine whether oral intravenous ibuprofen well efficacy tolerance closure patent ductus arteriosis extremely-low-birth-weight preterm infants.Seventy ELBW preterm infant patent ductus arteriosis enrol prospective-randomized study . Patients receive either intravenous oral ibuprofen initial dose 10 mg/kg , follow 5 mg/kg 24 48 h. One follow echocardiographic criterion duct size &gt; 1.5 mm , leave atrium-to-aorta ratio &gt; 1.5 , left-to-right shunting blood , end diastolic reversal blood flow aorta , poor cardiac function addition sign patent ductus arteriosis determine need ibuprofen treatment .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Birth weight 1000 gram Diagnosed patent ductus arteriosis Echocardiographic examination Accompanied congenital cardiac anomaly Severe thrombocytopenia &lt; 60.000 Severe intracranial bleeding ( Grade 34 ) Intestinal abnormality necrotising enterocolitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Patent ductus arteriosis</keyword>
	<keyword>Ä°buprofen</keyword>
	<keyword>Extremely Low Birth Weigh infant</keyword>
</DOC>